Basilea News http://basilea-elb.esono.de/ Basilea News en Wed, 19 Jun 2013 01:37:55 +0200 Wed, 19 Jun 2013 01:37:55 +0200 Chameleon CMS webmaster@basila.com (Webmaster Webmaster) webmaster@basila.com (Webmaster Webmaster) <![CDATA[Basilea presents first phase 1 data from its novel anti-cancer drug BAL101553 at ASCO conference]]> http://basilea-elb.esono.de/News-and-Media/Basilea-presents-first-phase-1-data-from-its-novel-anti-cancer-drug-BAL101553-at-ASCO-conference/6590397c-6022-f7ad-e89a-dcf3316f16e8 Tue, 04 Jun 2013 07:15:00 +0200 http://basilea-elb.esono.de/News-and-Media/Basilea-presents-first-phase-1-data-from-its-novel-anti-cancer-drug-BAL101553-at-ASCO-conference/6590397c-6022-f7ad-e89a-dcf3316f16e8 <![CDATA[Basilea reports isavuconazole orphan drug designation by U.S. FDA]]> http://basilea-elb.esono.de/News-and-Media/Basilea-reports-isavuconazole-orphan-drug-designation-by-U-S-FDA/0ef62e45-75c0-fa7a-cfe6-e0f31523b207 Tue, 28 May 2013 07:15:00 +0200 http://basilea-elb.esono.de/News-and-Media/Basilea-reports-isavuconazole-orphan-drug-designation-by-U-S-FDA/0ef62e45-75c0-fa7a-cfe6-e0f31523b207 <![CDATA[Basilea reports presentation of new data on anti-infective drug candidates addressing drug resistance]]> http://basilea-elb.esono.de/News-and-Media/Basilea-reports-presentation-of-new-data-on-anti-infective-drug-candidates-addressing-drug-resistance/469 Mon, 29 Apr 2013 07:15:00 +0200 http://basilea-elb.esono.de/News-and-Media/Basilea-reports-presentation-of-new-data-on-anti-infective-drug-candidates-addressing-drug-resistance/469 <![CDATA[Resolutions of the Ordinary General Meeting of Shareholders of Basilea Pharmaceutica Ltd.]]> http://basilea-elb.esono.de/News-and-Media/Resolutions-of-the-Ordinary-General-Meeting-of-Shareholders-of-Basilea-Pharmaceutica-Ltd-/461 Tue, 09 Apr 2013 17:13:53 +0200 http://basilea-elb.esono.de/News-and-Media/Resolutions-of-the-Ordinary-General-Meeting-of-Shareholders-of-Basilea-Pharmaceutica-Ltd-/461 <![CDATA[Basilea's Board proposes Martin Nicklasson to succeed Chairman Werner Henrich and recommends to shareholders that they do not support the request for a capital distribution at this time]]> http://basilea-elb.esono.de/News-and-Media/Basileas-Board-proposes-Martin-Nicklasson-to-succeed-Chairman-Werner-Henrich-and-recommends-to-shareholders-that-they-do-not-support-the-request-for-a-capital-distribution-at-this-time/459 Thu, 07 Mar 2013 07:15:00 +0100 http://basilea-elb.esono.de/News-and-Media/Basileas-Board-proposes-Martin-Nicklasson-to-succeed-Chairman-Werner-Henrich-and-recommends-to-shareholders-that-they-do-not-support-the-request-for-a-capital-distribution-at-this-time/459 <![CDATA[Basilea receives request to place repayment of CHF 48 million from capital contribution reserve on the agenda of the ordinary general meeting of shareholders]]> http://basilea-elb.esono.de/News-and-Media/Basilea-receives-request-to-place-repayment-of-CHF-48-million-from-capital-contribution-reserve-on-the-agenda-of-the-ordinary-general-meeting-of-shareholders/457 Fri, 22 Feb 2013 23:50:52 +0100 http://basilea-elb.esono.de/News-and-Media/Basilea-receives-request-to-place-repayment-of-CHF-48-million-from-capital-contribution-reserve-on-the-agenda-of-the-ordinary-general-meeting-of-shareholders/457 <![CDATA[Basilea reports 2012 financials with a solid cash position and significant milestones ahead]]> http://basilea-elb.esono.de/News-and-Media/Basilea-reports-2012-financials-with-a-solid-cash-position-and-significant-milestones-ahead/456 Thu, 07 Feb 2013 07:15:00 +0100 http://basilea-elb.esono.de/News-and-Media/Basilea-reports-2012-financials-with-a-solid-cash-position-and-significant-milestones-ahead/456 <![CDATA[Basilea reports recruitment completion of phase 3 pivotal study of isavuconazole, an agent for the potential primary treatment of invasive and life-threatening fungal infections]]> http://basilea-elb.esono.de/News-and-Media/Basilea-reports-recruitment-completion-of-phase-3-pivotal-study-of-isavuconazole-an-agent-for-the-potential-primary-treatment-of-invasive-and-life-threatening-fungal-infections/465 Fri, 14 Dec 2012 07:15:00 +0100 http://basilea-elb.esono.de/News-and-Media/Basilea-reports-recruitment-completion-of-phase-3-pivotal-study-of-isavuconazole-an-agent-for-the-potential-primary-treatment-of-invasive-and-life-threatening-fungal-infections/465 <![CDATA[Basilea appoints Ronald Scott as CEO to succeed Anthony Man and expands management team]]> http://basilea-elb.esono.de/News-and-Media/Basilea-appoints-Ronald-Scott-as-CEO-to-succeed-Anthony-Man-and-expands-management-team/467 Mon, 10 Dec 2012 07:15:00 +0100 http://basilea-elb.esono.de/News-and-Media/Basilea-appoints-Ronald-Scott-as-CEO-to-succeed-Anthony-Man-and-expands-management-team/467 <![CDATA[Basilea initiates next phase 1 multiple ascending dose study with antibiotic BAL30072 active against multidrug-resistant Gram-negative bacteria]]> http://basilea-elb.esono.de/News-and-Media/Basilea-initiates-next-phase-1-multiple-ascending-dose-study-with-antibiotic-BAL30072-active-against-multidrug-resistant-Gram-negative-bacteria/450 Thu, 22 Nov 2012 07:15:00 +0100 http://basilea-elb.esono.de/News-and-Media/Basilea-initiates-next-phase-1-multiple-ascending-dose-study-with-antibiotic-BAL30072-active-against-multidrug-resistant-Gram-negative-bacteria/450